Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Roswell Park Cancer Institute
University of Washington
Institute of Hematology & Blood Diseases Hospital, China
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Nantes University Hospital
Children's Hospital of Philadelphia
St. Jude Children's Research Hospital
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Aarhus University Hospital
Comenius University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Nice
Wake Forest University Health Sciences
St. Jude Children's Research Hospital
University of Florida
Princess Maxima Center for Pediatric Oncology
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Washington University School of Medicine
Murdoch Childrens Research Institute
University of Miami
PedAL BCU, LLC
University of Rochester
Dana-Farber Cancer Institute
St. Justine's Hospital
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
Northside Hospital, Inc.
St. Jude Children's Research Hospital
University of Arizona
Sun Yat-sen University
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Geneve TEAM Ambulances
Assiut University
Mayo Clinic
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
University of Chicago